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Botulinum neurotoxin type A (BoNT/A) inhibits neu-
rotransmitter release by specific cleavage of SNAP-25, a
synaptosome-associated protein also expressed in the
ACTH secretory cell line AtT-20. Expression of light
chain BoNT/A (L-BoNT/A) gene transfected into AtT-20
cells resulted in a cleaved form of SNAP-25 indistin-
guishable from that generated by bona fide BoNT/A. L-
BoNT/A-transfected cells showed no difference in repli-
cation rate, viability, or phenotype, compared with
control AtT-20 cells. In contrast, L-BoNT/A-transfected
cells could not be induced to secrete ACTH upon stimu-
lation by 8-bromo-cAMP or KCl. In addition, a-latrotoxin
induced ACTH release from control cells, but not from
L-BoNT/A-transfected cells. These experiments suggest
an important role for SNAP-25 in regulated secretion
from AtT-20 cells and underline the usefulness of this
cell system as a tool for the study of the molecular mech-
anism of peptide hormone secretion.
There is increasing evidence indicating that regulated secre-
tion is controlled by a limited set of proteins (1, 2), such as
synaptobrevin, syntaxin, and SNAP-25,1 which are also com-
ponents of the docking and fusion machinery of synaptic vesicle
exocytosis (3). These neuronal proteins form a complex also
found in endocrine cells (4–7). Besides its essential role in
synaptic vesicle exocytosis, SNAP-25 is involved in neurite
elongation and synaptogenesis (8, 9) and is the molecular sub-
strate of the botulinum neurotoxin types A and E (10, 11),
which selectively block neurotransmitter release (12).
Like the other clostridial neurotoxins, botulinum neurotoxin
type A (BoNT/A) is a dichain molecule formed by a light (Mr
50,000) and a heavy (Mr 100,000) chain linked by a single
disulfide bond (13). The heavy chain is responsible for neuros-
elective recognition and binding of the toxin to ecto-acceptors at
neuromuscular junctions and mediates the internalization of
the active moiety of the toxin into nerve terminals (12–14). The
light chain is a Zn21-dependent protease that specifically
cleaves SNAP-25 (10). Such protease activity is considered to
be the molecular basis of the neurotransmission blockade by
BoNT/A (12). BoNT/A inhibits exocytosis in cells not displaying
selective acceptors on their plasma membranes, provided the
neurotoxin light chain is introduced in the cells bypassing the
recognition and binding steps (e.g. by microinjection or by using
permeabilizing agents, such as streptolysin-O or digitonin, or
by electroporation) (6, 15–17).
Successful expression of clostridial neurotoxins has been
achieved by transient transfection of the tetanus toxin gene
into COS cells (18) and by microinjection of Aplysia neurons
with tetanus toxin and BoNT/A mRNA (19). However, there
have been no reports of permanent transfectants expressing
the botulinum neurotoxins. The light chain of BoNT/A (L-
BoNT/A) permanently transfected into nonneuronal cells
should also be expressed and cleave SNAP-25. This approach,
avoiding more aggressive permeabilizing methods, would also
generate stably transfected cell lines useful in long term
studies.
AtT-20 endocrine cells express high levels of SNAP-25 and
secrete ACTH in response to stimulation with a variety of
secretagogues. To study the role of SNAP-25 in regulated se-
cretion, in this work we analyzed ACTH secretion from AtT-20
cells stably transfected with the L-BoNT/A gene and expressing
the functional toxin.
EXPERIMENTAL PROCEDURES
Plasmid Construction—cDNA encoding L-BoNT/A was kindly pro-
vided by Dr. H. Niemann (Hannover, Germany). The entire L-BoNT/A
coding sequence was amplified by polymerase chain reaction, using for
40 cycles the following parameters: denaturation 40 s at 95 °C; anneal-
ing, 40 s at 53 °C; and extension at 74 °C, 40 s. HindIII and XbaI
restriction sites were included in the sense and antisense amplification
primers, respectively. The polymerase chain reaction product was ex-
cised with HindIII and XbaI and cloned into the HindIII/XbaI-digested
pRC/CMV vector (Invitrogen, San Diego, CA). The pRC/CMV vector
contains the cytomegalovirus promoter and a neomycin resistance gene
for selection of stably transfected cells in a medium containing the
antibiotic G418 (Life Technologies, Inc.). Polymerase chain reaction
products cloned in pRC/CMV were sequenced to confirm the presence of
L-BoNT/A sequences. Special attention was given to the catalytic
domain.
Primary Cell Cultures and Growth of GH3 Cells—Pituitary cell cul-
tures from male Sprague-Dawley rats (200–250 g) and rat GH3 cells
obtained from ICN Biomedicals (Thame, Oxfordshire, UK) were pre-
pared and grown as described previously (7).
Growth and Transfection of AtT-20 Cells—An AtT-20 mouse anterior
pituitary cell line was obtained from the American Tissue Culture
Collection (ATCC, Rockville, MD). Cells were routinely grown at 37 °C
in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
bovine serum (Life Technologies, Inc.) and 2 mM/liter glutamine (Life
Technologies, Inc.), in a humidified atmosphere of 5% CO2 and 95% air.
AtT-20 cells were transfected with 2.5 mg of the DNA constructs (pRC/
CMV-BoNT/A) or the parental vector (pRC/CMV) using Lipofectin ac-
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cording to the manufacturer’s instructions (Life Technologies, Inc.).
After 48 h, stably transfected cells were selected by treatment with 0.5
mg/ml Geneticin (G418; Life Technologies, Inc.). Isolated individual
clones were maintained in the presence of G418.
Cleavage of SNAP-25 by BoNT/A—BoNT/A was produced from a
culture of Clostridium botulinum type A (NCTC no. 2916) as described
previously (20). AtT-20 cell homogenates (50 mg of protein) were incu-
bated with BoNT/A (100 nM final concentration) in 10 mM Hepes/KOH
buffer, pH 7.2 containing 100 mM KCl, 40 mM NaCl, 10 mM dithiothre-
itol and 0.5% Triton X-100. Incubation proceeded for 1 h at 37 °C and
was followed by fractionation in SDS-PAGE, 12.5% gel, and immuno-
blot analysis.
Immunoblot Analysis—Immunoblot analysis was performed as de-
scribed previously (7). 12.5% SDS-PAGE gels were electroblotted to
nitrocellulose membranes. The membranes were blocked in a solution
consisting of 5% non-fat milk powder in TBS (140 mM NaCl, 10 mM
Tris/HCl, pH 7.4, and 0.1% Tween 20) for 1 h at room temperature. The
blocked membranes were individually incubated with antibodies, in
blocking buffer, at the indicated concentrations: anti-a-tubulin, 1/1000
(Sigma); anti-SNAP-25, 1/1000 (SMI 81, Sternberger Monoclonals Inc.,
Baltimore, MD); anti-Rab3A, 1/2000 (21); anti-syntaxin 1, 1/2000
(HPC1) (22); anti-synaptobrevin 2, 1/2000 (23). After several washes
with blocking solution, membranes were incubated for 1 h with a
peroxidase-conjugated secondary antibody, and peroxidase activity
was detected using the enhanced chemiluminescent method (ECL,
Amersham Corp.).
Immunoprecipitation—AtT-20 cells were collected by centrifugation,
washed once with 50 mM Tris/HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA,
and lysed by resuspending the cells in the same buffer containing 1%
Nonidet 40 and 1 mM phenylmethylsulfonyl fluoride. After 30 min on
ice, nonsoluble material was removed by centrifugation for 10 min at
14,000 3 g. Anti-SNAP-25 monoclonal antibody (SMI-81) was added to
the supernatant and incubated for 4 h at room temperature. Protein
G-Sepharose beads (Pharmacia Biotech, Sweden) were then added, and
the mixture was incubated for 90 min at room temperature. The Sepha-
rose beads were then rinsed twice in the same buffer, twice in 50 mM
Tris/HCl, pH 7.4, 350 mM NaCl, and 1% Nonidet 40, and twice with 50
mM Tris/HCl, pH 7.4, 150 mM NaCl, without detergent and then pro-
cessed for SDS-PAGE and immunoblot analysis.
Immunocytochemistry—L-BoNT/A-transfected and control mock-
transfected cells were plated onto poly-D-lysine-coated glass coverslips
in 24-multiwell plates and grown in 2 mM 8-Br-cAMP for 4 days to
induce the appearance of large and extended cellular processes (24).
Cells were washed in phosphate-buffered saline and fixed with 4%
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, for 30 min. Fol-
lowing further rinsing, cells were preincubated in phosphate-buffered
saline containing 5% fetal calf serum and 0.1% Triton X-100. Incuba-
tions with primary antibodies against a-tubulin, SNAP-25, Rab3A, and
ACTH (Dako, Glostrup, Denmark) were done overnight at 4 °C in
phosphate-buffered saline containing 0.1% Triton X-100 and 0.2% gel-
atin. The immunocytochemical detection of antibodies was done using
the Vectastain ABC kit (Vector Laboratories, UK).
ACTH Release—Cells were plated in 35-mm tissue culture dishes
coated with poly-D-lysine to minimize cell loss and grown for 5–6 days
to near confluence. Before the experiments, cells were rinsed twice with
serum-free Dulbecco’s modified Eagle’s medium and then incubated at
37 °C in 5% CO2 in 1 ml of serum-free Dulbecco’s modified Eagle’s
medium containing the appropriate test substances. At the indicated
times after incubation, conditioned medium was collected from each
dish, centrifuged at 14,000 3 g for 5 min, and stored at 220 °C until
assayed for ACTH content. All tests were done at least in quadruple in
two independent experiments. ACTH was determined by a two-site
immunoradiometric assay (Allegro IRMA, Nichols Institute, San Juan
Capistrano, CA), using synthetic human ACTH1–39 as the standard
(25). All test were done in duplicate. 5 mM 8-Br-cAMP (Sigma), high (55
mM KCl) extracellular potassium concentration, and 3 nM a-latrotoxin
(Alomone, Israel) were used to stimulate secretion. Before use in AtT-20
cells the excitatory capacity of a-latrotoxin was tested by measuring
glutamate release in rat brain synaptosomes (26). The secretion data
presented are the mean 6 S.E. determined by a two-tailed, unpaired t
test.
RESULTS
Cleavage of SNAP-25 in L-BoNT/A-transfected Cells—The
pituitary-derived cell line AtT-20 selected for these transfec-
tion studies contained considerably higher levels of SNAP-25
than other anterior pituitary cell types (Fig. 1).
Geneticin-resistant AtT-20 cells transfected with the L-
BoNT/A gene were tested for expression of L-BoNT/A protease
activity by immunoblot analysis of SNAP-25 to show the ap-
pearance of the L-BoNT/A-specific SNAP-25 proteolytic frag-
ment. Of the antibiotic-resistant clones having variable capac-
ity to cleave SNAP-25 (data not shown) a clone (cl.2) showing
complete L-BoNT/A specific cleavage of SNAP-25 was chosen
for further studies (Fig. 2A).
The cleaving activity on SNAP-25 in the L-BoNT/A transfec-
tants was indistinguishable from that of bona fide BoNT/A.
Incubation of AtT-20 cell homogenates from either control
FIG. 1. Immunoblot analysis of SNAREs proteins in anterior
pituitary-derived cells. Samples (12 mg of protein/lane) from anterior
pituitary primary cell cultures, AtT-20 cells, and GH3 cells were ana-
lyzed by immunoblotting for the presence of syntaxin 1, SNAP-25,
synaptobrevin 2, and a-tubulin. Longer exposures of the films revealed
the presence of syntaxin 1 in AtT-20 cells (see also Fig. 3).
FIG. 2. A, immunoblot analysis of SNAP-25 and a-tubulin in samples
from wild type (w.t.), control (cl.13), and L-BoNT/A transfected (cl.2)
cells, which were previously incubated in the presence or absence of
BoNT/A (100 nM final concentration). Note the different SNAP-25 elec-
trophoretic mobility (arrows), corresponding to intact and degraded
(asterisk) SNAP-25 forms. B, silver-stained SDS-PAGE analysis from
control (cl.13) and L-BoNT/A-transfected (cl.2) cells, which were previ-
ously incubated in the presence or absence of BoNT/A (100 nM final
concentration). No differences in protein bands between control and
L-BoNT/A-transfected cells were observed.
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clones (cl.13), transfected with parental vector only, or wild
type cells with exogenous BoNT/A, resulted in the appearance
of the cleaved form of SNAP-25 having identical size to that of
SNAP-25 fragments derived from the L-BoNT/A-transfected
cells (cl.2) (Fig. 2A). Furthermore, no additional protein bands
were detected when cell extracts from L-BoNT/A-transfected
clones were incubated with the exogenous BoNT/A (Fig. 2A).
Expression of L-BoNT/A had no detectable effect on the protein
composition of the transfected cells as revealed by Coomassie
Blue or silver staining of SDS-PAGE gels of cell lysates from
control and L-BoNT/A-transfected cells (Fig. 2B).
The cleaved form of SNAP-25 in L-BoNT/A-transfected cells
retained the capacity to form protein complexes with synapto-
brevin 2 and syntaxin 1. Immunoprecipitation experiments
followed by immunoblot analysis show that anti-SNAP-25
monoclonal antibodies recognized and immunoprecipitated
with equal efficiency both the intact and the L-BoNT/A-cleaved
forms of SNAP-25 (Fig. 3).
L-BoNT/A Expression Does Not Affect Viability and Mor-
phology of AtT-20 Cells—L-BoNT/A-transfected cells displayed
no apparent difference in viability, replication rate, or pheno-
type compared with wild type or control transfected cells. In
addition, no differences in morphology were detected between
L-BoNT/A-transfected cells exhibiting complete cleavage of
SNAP-25 and control cells, showing an AtT-20 characteristic
pattern of processes (Fig. 4). a-Tubulin also showed similar
intracellular distribution in wild type, control cells, and L-
BoNT/A-transfected cells (Fig. 4). In addition, in L-BoNT/A-
transfected cells, secretory granule (ACTH), synaptic-like mi-
crovesicle (Rab3A) markers, and SNAP-25 showed the same
distribution pattern as that of control cells (Fig. 4).
Stimulated Secretion of ACTH Release—We examined
whether L-BoNT/A transfected cells retained the capacity to
release hormone upon appropriate stimulation. Basal release of
ACTH (27) was not significantly different in L-BoNT/A-trans-
fected and control cells after a 15-min (p . 0.5) (Fig. 5A) or a
60-min release period (p . 0.5) (Fig. 5B). In contrast, when
cells were stimulated for 15 min with a high (55 mM) concen-
tration of extracellular potassium, a significant increase was
observed in ACTH released from control cells compared with
L-BoNT/A-transfected cells (p , 0.03) (Fig. 5A).
Stimulation with 8-Br-cAMP and a-latrotoxin for 60 min also
failed to induce ACTH secretion from L-BoNT/A transfectants
(Fig. 5B). An induced increase of cytosolic calcium by a 5 mM
concentration of the cAMP analog 8-Br-cAMP (28) resulted in
the release to the medium of ACTH from control cells (p , 0.01)
but failed to stimulate release of the hormone from L-BoNT/A-
transfected cells (p . 0.5). In a similar manner, treatment with
a-latrotoxin (29) at 3 nM concentration resulted in the release of
ACTH from control cells (p , 0.05) but not from L-BoNT/A-
transfected cells (p . 0.5). Furthermore, simultaneous use of
8-Br-cAMP and a-latrotoxin resulted in even higher increases
in released ACTH from control cells (p , 0.01) but again failed
to stimulate hormone release from L-BoNT/A-transfected cells
over basal levels (p . 0.5) (Fig. 5B).
DISCUSSION
The L-BoNT/A gene, coding for a protease that specifically
targets the carboxyl terminus of SNAP-25 (10, 12), was intro-
duced into ACTH-secreting AtT-20 cells as a probe to investi-
gate the role of SNAP-25 in regulated secretion.
L-BoNT/A-transfected cells but not mock-transfected control
cells expressed an L-BoNT/A activity indistinguishable from
that of bona fide BoNT/A. The extent of SNAP-25 processing in
L-BoNT/A transfectants was variable, a provable consequence
of different dosages of genome-integrated L-BoNT/A sequences.
The majority of cellular parameters we tested were unaf-
fected by expression of L-BoNT/A. Furthermore, transfected
cells expressing L-BoNT/A activity at the highest level showed
no detectable changes in viability and growth rate when com-
pared with control cells, in agreement with previous studies
showing that BoNT/A toxin injected into muscles or added to
neuronal cell cultures caused no physical or morphological
damage to neurons (30–32).
The similar cellular distribution of SNAP-25 in control and
transfected cells suggests that synthesis, distribution, and sort-
ing of this protein was not affected by L-BoNT/A. In contrast to
FIG. 3. Immunoprecipitation of SNAP-25-containing protein
complexes from Nonidet 40 extracts of brain, control (cl.13) and
L-BoNT/A-transfected (cl.2) cells were analyzed by immunoblot
for the presence of syntaxin 1, SNAP-25, and synaptobrevin 2.
Cleaved SNAP-25 in L-BoNT/A-transfected cells (cl.2) is able to form
protein complexes with syntaxin 1 and synaptobrevin 2. Note the
cleaved form of SNAP-25 in L-BoNT/A-transfected cells. P, pellet; S,
supernatant.
FIG. 4. Immunocytochemical location of a-tubulin (A and B),
ACTH (C and D), Rab3A (E and F), and SNAP-25 (G and H) in
control (A, C, E, and G) and L-BoNT/A-transfected AtT-20 (B, D,
F, and H) cells. A and B, a-tubulin immunoreactivity is occupying the
cytoplasmatic areas. C–F, secretory granule and synaptic-like mi-
crovesicles markers (ACTH and Rab3A) are restricted to the tips of the
AtT-20 processes and to their Golgi regions. G and H, SNAP-25 immu-
noreactivity is located mainly at the plasma membrane. Arrows indi-
cate the Golgi region. Scale bars: A–F, 20 mm; G and H, 30 mm.
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the observation of others (9), showing that BoNT/A impairs
neurite extension and formation of new synapses in neuronal
primary cell cultures, our data show that cellular processes,
containing secretory granules and synaptic-like microvesicles
typical of AtT-20 cells (24, 33, 34), were unaffected by expres-
sion of L-BoNT/A. This suggests that SNAP-25 is not essential
for the elongation of cellular processes and transport of secre-
tory organelles in AtT-20 cells. A plausible means of reconciling
our results with those reports (9) is the finding of a non-
neuronal form of SNAP-25, SNAP-23, that could fulfill the
same role of SNAP-25 in AtT-20 cells (see below) (35).
The stimulus-evoked hormone secretion of ACTH, but not
basal secretion, was completely blocked in L-BoNT/A-trans-
fected cells regardless of the stimulus used, 8-Br-cAMP, KCl,
a-latrotoxin, or both together, confirming a significant role of
SNAP-25 in regulated exocytosis (10). A similar inhibitory ef-
fect of BoNT/A has been shown on insulin secretion from per-
meabilized pancreas-derived cells (6, 17).
The present report shows that at low concentration a-latro-
toxin, an inducer of neurotransmiter and neuropeptide release
from nerve terminals (29, 36, 37), evokes ACTH secretion from
AtT-20 cells over basal levels, suggesting the presence of an
a-latrotoxin receptor in these endocrine cells. Our finding that
a-latrotoxin was unable to restore ACTH secretion in L-BoNT/
A-transfected AtT-20 cells is in contrast with data showing that
this toxin can stimulate neurotransmiter release from BoNT/
A-poisoned nerve terminals (38). These observations may sug-
gest the existence of different mechanisms in neurons and
endocrine cells for the a-latrotoxin-induced secretion.
One of the most remarkable features observed in L-BoNT/A-
transfected AtT-20 cells was that the basal secretion level of
hormone was not significantly affected. One possible explana-
tion for this result is that SNAP-23, a SNAP-25 homologue
lacking the peptide bond cleaved by L-BoNT/A (35), may also be
responsible for constitutive and/or basal secretion level of
ACTH.
As far as we know the present report is the first successful
attempt to obtain a stably transfected secretory cell line ex-
pressing the light chain of botulinum neurotoxin. This feature
is especially relevant since the main effect of these toxins, the
impairment of the regulated exocytosis, becomes amenable to
study in secretory non-neural cells for long periods of time.
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3. Söllner, T., Whiteheart, S. W., Brunner, M., Erdjument-Bromage, H.,
Geromanos, S., Tempst, P., and Rothman, J. E. (1993) Nature 362, 318–324
4. Jacobsson, G., Bean, A. J., Scheller, R. H., Juntti-Berggren, L., Deeney, J. T.,
Berggren, P. O., and Meister, B. (1994) Proc. Natl. Acad. Sci. U. S. A. 91,
12487–12491
5. Roth D., and Burgoyne R. D. (1994) FEBS Lett. 351, 207–210
6. Sadoul, K., Lang, J., Montecucco, C., Weller, U., Regazzi, R., Catsicas, S.,
Wollheim, C. B., and Halban A (1995) J. Cell Biol. 128, 1019–1028
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concentrations for 15 min (A) or with 5 mM 8-Br-cAMP and 3 nM
a-latrotoxin for 60 min (B). ACTH released was determined by specific
radioimmunometric assay. Bars represent the mean value of at least
four determinations from one independent experiment, whereas error
bars represent values 6 S.E. Asterisks indicate differences from control:
*p , 0.01, **p , 0.05), and ***p , 0.03.
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